Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bought back in yesterday afternoon...I see good potential...seems like it's bottoming...time will tell good luck to all (except the shorts of this stock).
We have a change over in investor relations rep. We should be getting our annual Proxy Ballot and am 8k announcing annual meeting.
Should be a video conference with Q&A session. This is FY2022 1Q. Last quarter was once targeted as our BIG MOMENT. COVID delay. Hope you all participate.
May be something of GREAT NOTE in our proxy ballot :). ¯\_(?)_/¯
GLTUA
LAST day of TYME's FY 2021. Looks like no news to bust out with. Annual earnings early May normally and IR says that's remaining.
With end of quarter, a 4k is now due for the 100 million buy-in.
There's no reason for further pumps. They're funded and we're trying for that $100 mill for the whole year prior with an outstanding Shelf offering (IP to janitorial supplies up for sale).
The pump did help longs for less dilution. My feeling. Massachusetts General is our partner in TYME-19 trials; and that COULD make the news before today"s cl0se.
GLTA
Goog Question. Nuthing on SEC's EDGAR site Chillin'.
Called IR today, got a rehash from last time, and I have to call him.
Our annual earnings is due out in May where Cunningham will finally introduce himself and provide ..... OUTLOOK and zhit like that.
Unless we have an 8K (business update) released with REAL changes, that's the plan.
Ahhh, not thrilled with that. He thanked me for the Seeking Alpha article.
Whats up with that 1.3mil transaction after hours 4:00-4:10
Thanks Control It!
I put in a Request for Information to our Investor Rep this afternoon. I'm following with a call. Rich Cunningham, our new CEO seems to have cut responces. We'll see::
Yeah World, I've accepted Dumerjian'd and Hoffman's sales as managed reduction vs. A dump to salvage anything.
The Form 144 version are being updated by paper mail ins then manually filed, difficult to track. I have an SEC complaint in AND haven't bugged them for a couple of months. I'll get to it but don't expect much
We have had a board shake up with both our CFO and CTO also leaving. Supposedly for "personal opportunities". Neither has sold any of their holdings.
Not happy about any of these departures. But there they are.
Moving forward.
GLTUA
Selling is also not the best predictor of the future. Lots of reasons why insiders sell. To buy a yacht, pay for kids college, buy a new home, etc. Buying is much better predictor.
Both Mike Dumergian and Steve Hoffman are the original finaciers of TYME, both still holding more than 20 million shares each.
We don't like it. Both sell offs will eventually be around 8% of each formal holdings.
The sell-offs are pre-declared on 8Ks and recorded through SEC 144 plans. Haven't found those yet.
DumerjiAn evidently botched a breast cancer clinical trial. By-passing CDC protocol. Stock tanked. Severance package removed him from operational position.
Hoffman? Really don't know if there was a trigger. Still a major holder.
All I have
Both Mike Dumergian and Steve Hoffman are the original finaciers of TYME, both still holding more than 20 million shares each.
We don't like it. Both sell offs will eventually be around 8% of each formal holdings.
The sell-offs are pre-declared on 8Ks and recorded through SEC 144 plans. Haven't found those yet.
DumerjiAn evidently botched a breast cancer clinical trial. By-passing CDC protocol. Stock tanked. Severance package removed him from operational position.
Hoffman? Really don't know if there was a trigger. Still a major holder.
All I have
This is a lot of insider selling in 2021! What's the reason for the loss of interest?
3/9/2021 Steve Hoffman Insider Sell 41,750 $1.92 $80,160.00 24,614,998
3/8/2021 Michael Demurjian Major Shareholder Sell 20,000 $1.85 $37,000.00 24,798,546
3/1/2021 Michael Demurjian Major Shareholder Sell 20,000 $2.10 $42,000.00
2/16/2021 Michael Demurjian Major Shareholder Sell 20,000 $2.77 $55,400.00 24,858,546
2/1/2021 Michael Demurjian Major Shareholder Sell 20,000 $1.69 $33,800.00 24,898,546
1/25/2021 Michael Demurjian Major Shareholder Sell 20,000 $2.07 $41,400.00 24,918,546
1/21/2021 Steve Hoffman Insider Sell 56,250 $1.89 $106,312.50 25,868,998
1/19/2021 Michael Demurjian Major Shareholder Sell 20,000 $1.95 $39,000.00 24,938,546
1/11/2021 Michael Demurjian Major Shareholder Sell 20,000 $1.62 $32,400.00 24,958,546
1/5/2021 Steve Hoffman Insider Sell 56,250 $1.36 $76,500.00 24,981,498
Transcript: The Rachel Maddow Show, 3/11/2021
https://www.msnbc.com/transcripts/transcript-rachel-maddow-show-3-11-2021-n1261004
Found it doing a search on your last post. Thanks.
Not able to find the actual video.
Full interview. Heading out, lost link.
MADDOW: President Biden said tonight he`s not going to need the full 100 days that he promised to get to 100 million vaccine doses administered. He said tonight he expects that we`ll be at 100 million shots given by day 60 of his presidency. Not by day 100. Day 60 is soon. We`re already at day 51.
But even with beating that 100-day goal, even with vaccinating at a much faster pace than he initially promised, now, of course, many public health experts think we not only need to keep up this pace, we need to considerably accelerate it. The president did tonight say that he wants the U.S. pace of vaccination to stay at a sustained rate of more than 2 million shots per day, as a goal from here on out.
Again, all American adults eligible for the vaccine in every state and territory and tribe by the end of next month. Those are -- that`s a lot. Those are big things that he is promising and that he`s saying the government is going to be able to do. The president`s trying to raise spirits tonight. He`s acknowledging the loss that we have been through over the past year, in a way that no other American politician of his generation or any other that I have ever known can do and the way he`s able to articulate grief and empathy and sympathy.
He`s acknowledging the loss. He`s also trying to raise spirits by telling what it will take to get to the end of this crisis. And importantly, he asked for everybody to do their part. Not only does he want us all to get vaccinated, he said tonight, get vaccinated when it`s your turn and when you have the opportunity to get vaccinated, but help others get vaccinated.
Help your neighbors and your friends and your family get vaccinated too. So we can pull together toward a goal of being able to be together again safely and soon. And so this is an important address because of this milestone, because of where we are in the Biden presidency, because of what else is going on in the COVID response, but let me get specific here for a second, because there are ways this is going to go here that I think the scientific, the epidemiologists, the infectious disease experts, they understand here, but we the public don`t necessarily get it yet.
Let me give you a few things that I`m talking about here. If we open everything back up again, like they`re doing in Texas right now as we speak, and in Florida, and in Oklahoma, and in Mississippi, and all these other places, are we now vaccinating Americans fast enough that any subsequent surge in new cases, surge in hospitalizations, surge in deaths that we get from these wide openings that are happening in so many states, is it possible that we`re vaccinating enough
Americans now that those subsequent surges after these openings up won`t be as bad? Is it giving us some cushion, some insulation from further spikes like we have seen in the past after other states opened up?
With 90 percent of the American population still unvaccinated now, 10 percent vaccinated, can scientists discern an inflection point, where the effect of vaccines is protective enough that it`s not actually an irresponsible choice to open up?
Will we get to a point where the Dr. Faucis of the world and the CDC will give guidance on opening stuff up based on what proportion of the population is vaccinated? Is that day coming? Should we be heading toward that day already?
And then there`s the darker side of that question. If we are opening up in big parts of the country right now, if we`re opening up big parts of the country too early, before there are enough people vaccinated to make it safe to do so, could those opening ups actually fuel the rise of these more virulent variants of the virus against which the vaccines don`t work as well? Are we in effect breeding vaccine resistant strains by opening things up in lots of states and encouraging lots of viral transmission right now before we have got significant numbers of people vaccinated in those states? Or does it not work that way?
I feel like this is one of these issues that epidemiologists, infectious disease specialists` scientists who know this stuff, they understand the concepts, but we the public are still fuzzy on these things. We`re both worried about continued transmission, plateauing transmission.
Still, more than1,000 Americans dying every day, and we`re incredibly hopeful for not only the vaccinations we have had already, but for the pace at which we`re going to continue to vaccinate. How do we put those things together? There`s a scientific point at which those points come together. The scientists need to help us understand those as the public.
And one more. While we`re on the subject of hard questions that you might need a Dr. Fauci type to answer, here`s one that I find animating me more and more with each passing day. Imagine if you will, imagine just for a second, that we had basically a cure for COVID-19. A drug you could take if you did get COVID. It doesn`t prevent you from getting infected. It`s not a vaccine. But if you do get infected, it`s basically a cure or close to it.
Imagine if we had something like that. You know, you didn`t get vaccinated in time, and you got COVID. You tested positive, but then you can take a dose of this drug, and it`s highly effective at preventing you from being hospitalized. Like 70 percent effective or even more, 85 percent effective, 87 percent effective at keeping you from having to go to the hospital because of your COVID infection, at keeping you from dying.
Imagine if we had something like that, a drug you could take, if we had something that effective at effectively curing people who got infected with COVID. A drug you could take that would keep you from getting sick and dying. How would the availability of that affect our national response to this pandemic?
I`m asking because honestly, it seems like we might have that right now already.
But nobody is really talking about it. Two new clinical trial results reported yesterday showing for people who tested positive for COVID, people at high risk of getting sick and dying from COVID, take this drug, 85 percent and 87 percent reduction in your chance of getting hospitalized or dying. Two different drugs, one with an 85 percent reduction, one with an 87 percent reduction.
One of these drugs, the 87 percent one, is already approved for use in the United States. It`s made by Eli Lilly. Eli Lilly says they can make a million doses of that in the next few months. The other drug is made by Glaxo, and a biotech company called Vir.
They say they`re applying for use authorization in the United States right away on the strength of these clinical trial results. Their clinical trial was actually called off by the advisory board overseeing it because the drug was working so well, they decided the only ethical thing to do was to stop the trial. They decided it wasn`t ethically right to keep giving half the people in that trial just a placebo when the drug itself was working so well. It was showing an 85 percent reduction in people having to go to the hospital and in people dying. Among people who were COVID positive and at high risk of sick.
What if we had something that`s basically a cure? What if we have already got something that`s pretty close to a cure and we`re just not using it enough
Dr. Anthony Fauci briefed at the White House this week on new antiviral prospects for treating and potentially curing COVID, protease inhibitors, polymerase inhibitors, entry inhibitors -- surprising numbers of drugs to treat COVID in interesting stages of development right now. But there are three ;,possibly soon to be four antibody treatments already approved for use in the United States against COVID that are really, really, really, really highly effective for people who have COVID, who have been infected to keep them from getting sick.
The U.S. government has bought hundreds of thousands of doses of these drugs;. They`re paid for. But, by and large, they`re not being used while still even now we`re losing 1,500, 2,000 Americans every day. If that many deaths every day. While we have drugs that can significantly reduce the prospect of people dying from this illness.
I mean, COVID-19 is not considered to be a curable illness now, but for people who are infected who are at high risk from getting sick, this thing may be way more susceptible to treatment that we`re -- than we`re acting like. Why is that? Why is nobody talking about that?
I`m getting increasingly obsessed with this. We are one year in. We have vaccines now. We need to get everybody vaccinated. All adults eligible will be vaccinated by the end of next month. The president asking us all to help our neighbors and our friends and our family to get vaccinated too. We have the vaccines soon to be in more than sufficient quantities.
We also have some treatments now with proven clinical effectiveness. And in addition to getting everybody vaccinated to keep them from getting infected in the first place, we also need to acknowledge 50,000-plus Americans are still getting infected every day now.
And for people -- and hopefully that will go down with vaccines, but as of right now, we have been plateauing at 50,000 cases a day or more for a very long time. For people who do get COVID, for people who test positive who are at high risk of getting sick, it seems to me we need to get way more of those people access to the existing treatments that we`ve got that are going wanting right now, that are not being used while Americans die.
How do we fix that part of it? Why isn`t that more of a focus of our national discussion? Is there something that I`m missing here? Some way I`m looking at this the wrong way around?
Joining us now is our nation`s top infectious disease expert. He`s the director of the National Institute of Allergy and Infectious Diseases. He really needs no introduction beyond that.
Dr. Anthony Fauci, it`s a real honor to have you here tonight, sir. Thank you so much.
FAUCI: Thank you very much. Good to be with you, Rachel.
MADDOW: First of all, let me -- let me give you the chance to wind me back here ;,if I am looking at this the wrong way around --
MADDOW: -- or if anything that I just said is wrong or too fuzzy.
Fauci: No, part of what you said, a good part of what you said is true. The only difficulty is that when you`re dealing with something that requires an intravenous administration, the logistics of doing that on a wide scale is much more difficult than I think you made it appear.
What we really do need more of is orally administered pills like we have for HIV and hepatitis C, where someone can take them immediately. You don`t have to line up to go to an infusion center.
The other thing is you`re absolutely correct, though, that in fact some of the monoclonal antibodies are in fact really quite impressive if you get the treatment early enough. We have had a number of trials which you did not mention, when they were given to people later in the course of infection essentially did not work at all.
So, one of the things that`s very, very clear, if you administer those drugs and the logistic difficulty in getting people to infusion centers to do that makes it difficult to readily use it. But in and of themselves, they are quite effective if given early enough.
The other point that you obviously had no way of making or knowing is that when you get a variant, the monoclonal antibodies are very vulnerable to the variants because they`re very specific for a particular part of the virus ; . And when the virus mutates, if it mutates at that point that that monoclonal antibody binds to, then that`s it. That monoclonal antibody is no good.
We`ve learned that from the South African experience, where the virus that is now prevalent in South Africa, the 351 variant, that one knocks out many of the monoclonal antibodies people are using. So there`s not that real confidence that we now have the showstopper with monoclonal antibodies.
They have a place, but the real therapeutic end game would be an orally available drug that you could readily administer, that you could get in a pharmacy and a person could get it just like that when they get infected.
MADDOW: Is there an interim step?
I was interested to see that with the Glaxo treatment, they talked today in their results about their clinical trial, that they`re trying to basically reconfigure that drug so that it wouldn`t be administered at an infusion center infused in the way I think people may be familiar with, the way you get chemo, for example, in a lot of cases for oncological treatment. But they` ; re trying to configure that drug as a simple injection.
Now, that wouldn`t get you as far as --
Fauci: Right.
MADDOW: -- having a -- be a pill that you can take, but it would get you closer to being a more easily administered treatment.
Fauci: You`re absolutely correct. So, let me be clear, despite the caveats I just gave about the monoclonal antibodies they are potentially highly effective therapeutics. What many of the companies are working on, and many of the researchers involved, is to do just what you say, to modify it in a way that`s much more easily administrated ;>. Namely, being able to give it in a subcutaneous injection orit down to a way where you can give it intramuscularly or subcutaneously ;>, where you don`t have to have an infusion center. You could just go in, get an injection, and that`s it.
That`s the way the direction is going right now to facilitate the logistics of getting it into people.
MADDOW: Do you think, Dr. Fauci , that we are ultimately going to have coronaviruses ;> and COVID-19 essentially endemic, and we`re going to be shots that are like flu shots that are updated all the time to account for new variants, that it`s something we`re never going to eradicate but we`re going to be increasingly treating and trying to avoid through evolving vaccines?
Fauci: That is entirely conceivable. So, when you have infectious diseases, the three ways you go at them, you can control them, you can eliminate them ;,or you can eradicate them.
You`re absolutely correct. ;> It is unlikely that we will eradicate this, at least not in the near future, because of its widespread global spread that we have. That`s not going to happen.
You can possibly eliminate it if in fact you vaccinate enough people and you get the overwhelming majority of the population vaccinated, and you do get this veil or umbrella of herd immunity.
One of the stumbling blocks to that is that this is a global pandemic. So unless you essentially equally suppress it throughout the world or if you have places in the world where it`s still pretty much doing its thing without any control, you will always have the danger, even if you do a good job in the United States or Canada or the
European Union, that if you have parts of the world where there`s a lot of viral activity, the idea of a variant emerging, getting to your country, and then re-giving you another spike is a real danger.
So in answer to your specific question, it is conceivable that until we get a broader way of protection throughout the world, that we may have cycles where we have to keep boosting people, either boosting them with the original vaccine, which gives you enough antibody to spill over to the variants, or develop a vaccine that`s specific for one or more of the variants
The only trouble with the latter is that otherwise you may find yourself playing whack-a-mole with the variants, because we have a lot of different variants One was the U.K. Another one was the South African variant. We now have a couple of homegrown variants, one in
California and one in New
York.
So what you really need to do is get a vaccine that`s potent enough and broad enough that it will overlap all of the other variants. You can give that a name, more of a universal SARS-CoV-2 vaccine. That`s what we`re aiming at, so we don`t have to be repetitive every year coming back to chase after these variants.
MADDOW: This week, President Biden was asked what the United States will do with surplus vaccine if the U.S. government ends up buying more vaccine than we need to vaccinate our own population, and he said we will share it with the world.
Do you anticipate that in fairly short order that the U.S. can be in a position to help vaccinate the world?
Again, not as charity but because it`s the thing that needs to be done in order to defeat this thing worldwide because we are a nation that is more capable than most to be able to effectuate something like that around the world. Do you anticipate being-- us being in a global leadership role in that -- in that front?
Fauci: The answer is yes. And there`s more to it than just that. We`re part of this group called COVAX. We have already given $2 billion and we`re going to give another $2 billion for a total of $4 billion.
The president also said, and it`s true, that we will have a surplus, and when we do, we`re willing to give it to some of the countries that can`t fend for themselves.
But there`s also another thing we can do. We can partner with many of the other countries to give the resources to these other countries that don`t generally have the capability of making vaccines for themselves to allow them to ultimately be self-sufficient. In other words, instead of giving doses to them, giving them the capability of making doses themselves.
So, all of those different things I think are going in the right direction, because it`s quite true, this is a global pandemic, and it requires a global response. And if the entire world is not controlling it, then nobody is really going to absolutely control it.
MADDOW: Dr. Fauci, I`m so grateful to have this time with you tonight. If you don`t mind just taking a quick break with us, I have a couple more questions for you on the other side of the break.
Fauci: Sure. No problem.
With Bike Week getting under way at Daytona Beach this weekend, Main Street is already lined with motorcycles and business owners say they` ; re ready. The 80th anniversary of the event comes a year after it was cut short just as the pandemic was exploding. As worries remain this year, a mask mandate is in place. However, when it comes to enforcement, that`s in the hands of businesses.
UNIDENTIFIED
MALE: We will not force it. We let the people, if they want to do it, that`s up to them.
UNIDENTIFIED
MALE: I think it`s going to be big. I think it`s going to look like the pandemic never surfaced.
(END
MADDOW: It is Bike Week in Daytona Beach, Florida, this week, 300,000 people expected to congregate in the streets for a motorcycle rally that happens there once a year. The Daytona
Police say it`s up to business owners to enforce the mask mandate during Bike Week. Many business owners saying meh. They won`t. Remember last year, a motorcycle rally in Sturgis, South Dakota, drew just under half a million people, health officials later said that event caused the spread of COVID-19 cases to more than 20 states.
Back with us now is Dr. Anthony Fauci, President Biden`s chief medical adviser on COVID issues, the director of the National Institute of Allergy and Infectious Diseases.
Dr. Fauci, thank you again.
I have to ask if you are worried about this motorcycle week in Daytona, if it may end up having the kind of consequences that Sturgis had last year.
Fauci: I think there`s a big possibility that that`s exactly what would happen I just took a look at that clip, Rachel, and it really gave me chills just looking at it. I mean, I understand people want to get out and enjoy themselves and get back to what would have been normal a couple years ago ;
.
But we really just got to hang on a bit longer. We`re really going in the right direction as we heard from the president just a little while ago.
It`s really ill-advised to do something like that because you know as a matter of fact that people are not uniformly going to keep their masks on when they finish with the rally, they`re going to go to bars. They`re going to have fun, which is understandable. You can understand their wanting to do that.
But they`re likely going to be pulling back from some of the prudent public health measures. I just hope we don`t have another surge in that area from that ;. It is really ill-advised.
MADDOW: We have seen a number of governors in recent days rescind mask mandates Do you ever speak with any of those governs? Do they either consult with you or do you call them to try to talk about those decisions?
Fauci: You know, I haven`t spoken to governors as a group for a while. I get calls almost every day from one governor or another asking usually for some advice about what to do or plans they have, saying do you think this is a reasonable idea? They need some feedback.
I have not heard from the governors of the states that you mentioned, namely from Texas or Mississippi, about the idea of pulling back on the mask mandate. I have not heard from them.
MADDOW: One of the other things I have been thinking about, as President
Biden lays out this prospect of a very much advanced vaccination effort nationwide -- lots of federal resources, lots more vaccine supply, lots more ambitious goals in terms of who qualifies and how quickly, we`re seeing such different levels of performance from different states in terms of getting vaccines into arms.
We`re seeing states like Alaska, for example, do great in vaccinating a large portion of their population. A state like Connecticut is also doing well ;. I live in Massachusetts where they`re doing a pretty lousy job.
I wonder if part of the national effort here is to get less -- poorly performing states up to speed, to help them with best practices -- to hel them reconfigure their websites or reconfigure some of the ways they`re administering ;> things to get them to follow best practices from other places so we don`t have laggard states like Massachusetts and some others?
Fauci: Rachel, I think you just nailed it. That`s exactly the issue that needs to be addressed, and that`s the reason why what the president said very clearly before the speech and at the speech tonight is that we at the federal level are going to really partner with the states in a collaborative ;>, cooperative, and hopefully synergistic way where we`re opening up community vaccine centers, u to 500 of them, including in areas that have minority populations that generally don`t have easy access to the types of things, including vaccines.
We`re going to put vaccines in pharmacies, including those located in areas ;,again, that are underserved. We`re going to use mobile units that are going to get out into poorly served areas.
We`re going to increase dramatically the number of people who will be able to give the vaccination-- regular army military people, we`re going to get volunteers from retired physicians nurses, and other health care providers in order to get this machine running really smoothly.
That`s what the president was talking about tonight. That`s what he speaks to us in private about. And that`s when you see a much more uniform approach of efficiency of getting vaccines into people`s arms. That`s exactly what he was referring to tonight.
MADDOW: Dr. Fauci, I think it`s a comfort to a lot of Americans just to know that you are the president`s top adviser on these matters and that you are meeting with him regularly and that you are in communication with him.The president tonight told the country that one of the things he wants us all to do is listen to you when you talk to us about this disease and about the truth of this epidemic.
I feel like I have to ask you sort of the converse, is he always listening to you? Is there anything that you want the Biden administration to be doing or that you have advised them to do that they`re not doing?
Fauci: Not at all, Rachel. I mean, we speak with the medical group every single day, multiple times a day. We meet with Jeff Zients who is the person who is really one leading the medical group. We meet with the president at least once a week. We get involved with other types of Zooms with people on the team. We`re in constant contact.
The president says all the time, either directly to us or translating it through people like Ron Klain and Jeff Zients that he wants the science to rule what we do. Tell me what is scientifically sound, tell me what is sound from a public health standpoint, and we`ll do it. And there isn`t anything that I can think of where we said, this should or should not be done, and it wasn`t followed. Absolutely, without -- without any exceptions.
MADDOW: Let me ask you just one specific point. There had been an expectation that the guidance for vaccinated people would come out late last week. It ended up coming out a few days later than that. There had been some reporting that suggested there were discussions within the administration ;> about travel guidance and other specific parts of that. Were there any shenanigans there? Was the CDC interfered with --
Fauci: No.
MADDOW: -- at all in its ability to recommend what it thought was right?
Fauci: Absolutely not. Unqualified no. There was no interference at all. They were just fine-tuning a document. The CDC is very careful, Rachel. They want to get it right. They`re an evidence-based ;> organization and they want to make sure they have the evidence Where they don`t have the evidence, could they model it? If they can` ; t model, can they put good commonsense judgment?
What we saw with the first installation of recommendations is the first in a series that are going to be coming out one after the other. They will address travel. They will address workplace. They will address houses of worship
You`re going to see that coming out pretty quickly so that people will have recommendations ;>, what they can do now that we got a lot of people vaccinated So, you`re going to see that very soon.
MADDOW: Dr. Anthony Fauci, President Biden`s chief medical adviser, director of the National Institute of Allergy and Infectious Diseases -- Dr. Fauci, I am honored to have you here and have this time.
I`ll ask you as I did last time, if you are -- if the answer to those last two questions that I ask you changes, if there are shenanigans, if there is inappropriate political pressure, I hope that you will squawk. You will have an open invitation to be here any time to tell us if there`s anything going on we ought to know about. We`re so grateful for your work, sir.
Fauci: Thank you, Rachel. I haven`t changed at all over the last year, so I will tell it like it is all the time. I promise you.
MADDOW: We trust you for it. We trust you for it, sir.
Fauci: Thank you for having me.
Do you have a link to the interview?
Link to posting of US Patent synopsis for out COVID Treatment (TYME 19) on Justia at https://patents.justia.com/patent/10905698/.
TYME19 seems based on a naturally occuring salt compound TUDCA, and that is:What is TUDCA?
Tauroursodeoxycholic acid, or TUDCA is a bile acid derivative that’s naturally occurring in the body. It’s been used therapeutically in traditional Chinese medicine for millennia, for hepatic and biliary disordes. We only make small amounts of this health-giving compound in our body, but as you can see from my list above, this bile salt actually influences a ton of bodily functions. Traditional Chinese medical practitioners have known about the benefits of TUDCA for ages, prescribing it to help detoxify the liver, treat “heat illness” such as fever, spasms, and vision problems, and improve many other conditions. It’s only just recently been under the spotlight, becoming the subject of recent clinical studies as scientists examine its many potential and profound health benefits.Abbreviated Excerpt from Rachel Maddow's interview with Anthony Faucie. Mostly Rachel build up here. Fauci fairly succinct and to the point:
Imagine if we had something like that, a drug you could take, if we had something that effective at effectively curing people who got infected with COVID. A drug you could take that would keep you from getting sick and dying. How would the availability of that affect our national response to this pandemic?
I`m asking because honestly, it seems like we might have that right now already.
But nobody is really talking about it. Two new clinical trial results reported yesterday showing for people who tested positive for COVID, people at high risk of getting sick and dying from COVID, take this drug, 85 percent and 87 percent reduction in your chance of getting hospitalized or dying. Two different drugs, one with an 85 percent reduction, one with an 87 percent reduction.
One of these drugs, the 87 percent one, is already approved for use in the United States. It`s made by Eli Lilly. Eli Lilly says they can make a million doses of that in the next few months. The other drug is made by Glaxo, and a biotech company called Vir.
They say they`re applying for use authorization in the United States right away on the strength of these clinical trial results. Their clinical trial was actually called off by the advisory board overseeing it because the drug was working so well, they decided the only ethical thing to do was to stop the trial. They decided it wasn`t ethically right to keep giving half the people in that trial just a placebo when the drug itself was working so well. It was showing an 85 percent reduction in people having to go to the hospital and in people dying. Among people who were COVID positive and at high risk of sick.
What if we had something that`s basically a cure? What if we have already got something that`s pretty close to a cure and we`re just not using it enough......
I mean, COVID-19 is not considered to be a curable illness now, but for people who are infected who are at high risk from getting sick, this thing may be way more susceptible to treatment that we`re -- than we`re acting like. Why is that? Why is nobody talking about that?..................
Dr. Anthony Fauci, it`s a real honor to have you here tonight, sir. Thank you so much.
First of all, let me -- let me give you the chance to wind me back here ;,if I am looking at this the wrong way around -- or if anything that I just said is wrong or too fuzzy?FAUCI: Thank you very much. Good to be with you, Rachel.
Part of what you said, a good part of what you said is true. The only difficulty is that when you`re dealing with something that requires an intravenous administration, the logistics of doing that on a wide scale is much more difficult than I think you made it appear.
What we really do need more of is orally administered pills like we have for HIV and hepatitis C, where someone can take them immediately. You don`t have to line up to go to an infusion center......So the patent was submitted 06 July. Approved as Patent Claim announced on 03 March.
GLTUA
Got a positive call on us released at 11 AM.
May be the cause of our good day[/quote]InvestorsObserver is giving Tyme Technologies Inc (TYME) an Analyst Rating Rank of 78, meaning TYME is ranked higher by analysts than 78% of stocks. The average price target for TYME is $9.5 and analyst’s rate the stock as
Subject: Where Does Wall Street Think Tyme
https://www.investorsobserver.com/news/stock-update/amp/where-does-wall-street-think-tyme-technologies-inc-tyme-stock-will-go
Nice Article on THYME in Seeking Alpha.[/quote]LINK[/quote]A little frustrating with no news from TYME the last month. Not likely to see much until May, our 4th Quarter Earnings, per our Investor Relations rep, sent an RFI Tuesday, just called him yesterday, where he parroted the 4Q report coming in May.
Our FY is April to March, here's my RFI:
************************************
RFI: Last Month of FY 2021, Rich Cunningham Has No Policy/Platform for Retail Holders
Mon, Mar 1, 1:37 PM (5 days ago)
to ^?^?^?^?:
The few holders I do have contact with TYME before November 2019 Wall Street Opening Bell are fairly frustrated Brian with no news of how our new funding will be applied. Please pass our frustration up the ladder.
With the long open S1 open shelf finally close and $100 million, can we assume November's 2020 Corporate Presentation will be revised? Specifically:
.....(1) How are we going to apply these funds?
.....(2) Will we return and start Stage 3 Prostate?
.....(3) Any progress on Ewings Sarcoma with the Joseph Amend HOPES trial?
.....(4) Return to Breast Cancer status?
.....(5) Update on Precision Promise?
Really would appreciate at least a Zoom meeting chaired by Cunningham. We understand the TYME-19 PR was coordinated with the offering sale to limit dilution somewhat, and appreciate that. However, the CEO should be addressing us at this time.
VR
*************************************
So no text/email response. TYME Corporate Presentations normally released with updates before an funding effort. Hasn't been updated since November 2020/. On Inverstors' Section of TYMEs website. This is now our 2021 4th Quarter (FY 2021 4Q) and was supposed to be our MOMENT. Got pushed out to FY 2022 in November, the milestone dates removed for page 5 of the presentation.
I was told there would be no further funding. The presentation would be updated prior to our 4Q earnings with 10Q SEC filings.
The SA article helps close some of my questions. The point of TYME 19 not being advanced YET with the PROOF OF CONCEPT going is eye opening. 4th quarter was the original target. Nearly over.
GLTUA
Dunno Bagel, for the 3QFY21 (Oct --> December only have the Holdings Channel showing end of 2020 calendar year.
At that time, they'd reduced 2020 holdings.
Got two links.
https://fintel.io/so/us/tyme/blackrock
http://www.holdingschannel.com/bystock/?symbol=TYME
Fintel shows up to 5 million around May 2020
Check it out.
We're in 4th Quarter 2021 right now. Up to November, this WAS THE QUARTER. Now they're saying April is the earliest.
Start of FY2022.
GLTUA
I think Blackrock increased its position from last quarter to this quarter.
Here ya go PT, apologies for the long time it took me to get back to you. Top holders of TYME, from holdingsChannel. And you're right. Blackrock has been holding us for a bit.
<img>https://www.holdingschannel.com/holdings-channel-logo.jpg</img>
<img>https://www.holdingschannel.com/funds/holding-tyme.png</img></quote>[/quote]Link to Holdings Channel (TYME Listings)
Holder Amount Position Size
($ in 1000's) As of[/quote]
BlackRock Inc. 4,454,185 $5,433 12/31/2020
Vanguard Group Inc. 2,479,245 $2,429 09/30/2020
Hlthcare ValCap LLC 2,175,000 $2,132 09/30/2020
Hudson Bay Cap Mgt LP 1,956,632 $1,917 09/30/2020
State Street Corp 862,961 $846 09/30/2020
Geode Cap Manage LLC 861,899 $844 09/30/2020
Northern Trust Corp 768,299 $753 09/30/2020
Here's where we stand on Canxer trials. Hannuman. I have some info on Dumurjian below.
Still has over 20Millian shares. He and Hoffman
Got some links down below for study material data Mat0! On a scheduling note, just at the beginning of this CALENDAR YEAR, our board of directors were telling us the second half of 2020 was going to be our rocket-to-the moon. So I figured we'd be at least to countdown on the blast-off by now.
Before that, of the five trials list raised all sorts of problems and died on the vine. Successful breast cancer trial, without enough funding to properly complete. Da.... shame on that. Actual these first three links are three sides of the coin on that stalled, under-fund breast cancer study.
***************************************************
Links on BREAST CANCER
(1) Here is our wunder-ful wunder-ful positive testimonial link:
https://people.com/bodies/head-of-the-class-khrystyne-haje-recovered-stage-iv-breast-cancer/
(2) This link will get you a fairly succinct piece of where we were viewed ahh, negatively.
https://ihatebreastcancer.wordpress.com/2017/04/13/khrystyne-haje-and-the-sm-88-story/.
(3) This third one is the market perspective on the downfall that led to Red Bank Mike Demurgian's departure.
https://www.fool.com/investing/2019/01/18/heres-why-tyme-technologies-fell-35-on-friday.aspx#:~:text=Shares%20of%20Tyme%20Technologies%20(NASDAQ,patients%20with%20advanced%20pancreatic%20cancer.
***************************************************
Link to Clinical trials.gov site. Will takes a little time to practice with on what you play around trying to dig through the fields that will raise some questions in your mind. My method to use hitting on our Investor Relations rep, Brian Gill.
(1) https://clinicaltrials.gov/ct2/results?cond=&term=sm-88&cntry=&state=&city=&dist=&number=Link
That'll get you to status tables for all five. Play around on the top tool bar to view the fields you want. This next link is pretty cool to play with. Shows one study (the CT number for Clinical Trial ID reference).
You can compare the versions of all the data tables on each trial. I encourage you and all to play with it.
(2) https://clinicaltrials.gov/ct2/history//NCT03512756
*******************************************************
So we're in 2021 4th Qrtr. TYME's FY 2022. April supposed to be blast off April.
Head of the Class's Khrystyne Haje is in recovery from stage IV breast cancer after doctors initially gave her just two years to live
Head of the Class's Khrystyne Haje is in recovery from stage IV breast cancer after doctors initially gave her just two years to live
* * $TYME Video Chart 02-09-2021 * *
Link to Video - click here to watch the technical chart video
i grab a lot of shares under 2.5 offering price and notice insider and black rock own 4.5 million share
ihub can't post image
Nuthing on EDGAR Boss. SeekingAlpha aint listhing but the rise and volume. Any of the free-commercial sites lag by two weeks. Enjoying the ride. If you have site tell us. If you can post that image go for it. TIA
don't have link just image
Got a link there PT?
offer closed 100mil price 2.5 lol i already grab a lot below 2.5 offering price
Had some TYME and decided to buy some TYME @2.49
Noticed the unusual activity in after hours maxing out @2.99. Is there any news other than whats already officially out?
If I have TYME to kill, is it TYME to buy more TYME? Or is it TYME to sell some TYME?
Or just stand by since only TYME will tell?
Just passing through? Best of luck tall dark stranger. Leave your silver bullet, ride off in a cloud of dust. Enjoy your ride.
Kicka$$ volume. Two factors hitting HIGH NOTED:
Trading Volume Average 90,100
Market Cap. $1,051,943,100
Gotten and getting diluted. Short vol to retail no higher than 40% and a crazy 22 days ro cover.
.
A little shi÷ we gotta deal with.
GLTUA
* * $TYME Video Chart 02-04-2021 * *
Link to Video - click here to watch the technical chart video
TYME price action today is as interesting to follow as the EEG of a brain dead patient!
Thats a good read, I believe I will average up on this offering. Feeling good not being negative anymore lol. Forward ahead captain.
Feeling blessed.
Thinking we're good Chillin'. Staying long. Doing well with it and expect to do A LOT BETTER.
We're right on the timeline they've been presenting with report on our Proof of Concept on TYME-19 progress report coming in 2021 4th quarter and here we are.
This article from yesterday's gusher on Seeking Alpha puts the possibilities here way up there for me:
https://www.fool.com/investing/2021/02/03/why-tyme-technologies-stock-is-crushing-it-today/
FY22 starting on April 1st (yeah, joke there somewhere:). We can stick it.
Pretty content with sitting here for a bit.
Having a good year with the new administration too. Staying in Small & Midcaps as there as an infusion last time (2008). Thinking there'll be a repaly.
We'll get it.
Idk about you, but I expected the $100mil offering today after the news yesterday. Good entry point for new people, lower $2 range, while the offering is at 2.50. Hopefully it doesn't enter $1 territory anymore and we can continue forward to so new releases on clinical trials.
hi Mike
thanks for the info
its not a problem for me...I am still much in green...AND....anyway...I have another big winner at the moment (AVXL)....crazy whats going on there
very kind regards
mickyboy
Earnings filed after hours last night Mick. We don't have earnings. Everyting is CLINICAL TRIALS plus Research and Development.
We have a 50% cash burn teported for 3d quarter.
S1 just modified version of open shelf fund raiser. Instead of a FIXED RATE around $1.80 pps. We're being offered at market. Rate
Chúß
TYME Announces $100 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
And indeed, here it came and even worse, out of the market hours. Impossible to get rid of this TURD right now!
WITH THOSE PESKY BIOTECH COMPANIES ONLY THE SHORTS WIN MONEY (on the long run).
* * $TYME Video Chart 02-03-2021 * *
Link to Video - click here to watch the technical chart video
We have an open shelf offering pretty much all the time. No one has bought. This is majorly insider owned.
Eagle Pharmaceuticle
If you want to get burned go try the cannabis stocks. no pun intended. jeff sessions cost me and the cannabis industry lots of money.
Now that they have the patents, I'm fearing a public offering, got burned so often with those biotech companies right after good news ;-(
Nice going Mike!
Now having the patents there are many options. Another Pharm buys out TYME? Perhaps they simply start producing their product? Merge with another company? Receive Govt money?
Whatever happens TYME is now going to make shareholders money!
Followers
|
23
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
892
|
Created
|
08/04/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |